Your browser doesn't support javascript.
loading
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia.
Melén, Christopher M; Merrien, Magali; Wasik, Agata M; Panagiotidis, Georgios; Beck, Olof; Sonnevi, Kristina; Junlén, Henna-Riikka; Christensson, Birger; Sander, Birgitta; Wahlin, Björn Engelbrekt.
Afiliação
  • Melén CM; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
  • Merrien M; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Wasik AM; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Panagiotidis G; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Beck O; Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Sonnevi K; Unit of Clinical Pharmacology, University Hospital, Stockholm, Sweden.
  • Junlén HR; Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Christensson B; Unit of Clinical Pharmacology, University Hospital, Stockholm, Sweden.
  • Sander B; Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
  • Wahlin BE; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden.
Leuk Lymphoma ; 63(6): 1387-1397, 2022 06.
Article em En | MEDLINE | ID: mdl-35037561

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabinoides / Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabinoides / Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article